Physiomics awarded a Biomedical Catalyst GRANT from the UK Technology Strategy Board

Physiomics awarded a Biomedical Catalyst GRANT from the UK Technology Strategy Board

Physiomics is pleased to announce that it has been awarded a GBP148,465 grant from the UK’s innovation agency, the Technology Strategy Board’s Biomedical Catalyst fund. The grant will provide additional support for the development of the Company’s flagship Virtual Tumour Clinical platform.

Read more.